Peptide Self‐Assembly for Enhanced Cancer Therapy via Immunogenic Programmed Cell Death: Ferroptosis, Pyroptosis, Necroptosis, and Cuproptosis
Macromolecular Rapid Communications · 2026
DOI: 10.1002/marc.70400 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Rapid Communications, 2026. Verfasst von Shasha Ning und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China. Hauptthemen laut MEDLINE: Pyroptosis, Ferroptosis, Peptides, Necroptosis. Die Arbeit nennt 106 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Jiangsu Shuang Chuang Team.
Abstract (Originalsprache)
While immunotherapy has revolutionized cancer treatment, its clinical efficacy is still constrained by tumor heterogeneity, acquired drug resistance, and the immunosuppressive tumor microenvironment. Traditional apoptosis‐driven cancer therapeutic strategies are often inefficient and immunologically silent. In contrast, non‐apoptotic programmed cell death (PCD) pathways (ferroptosis, pyroptosis, necroptosis, and cuproptosis) offer high immunogenicity and the ability to bypass resistance mechanisms, yet their clinical application is limited by poor tumor specificity, off‐target toxicity, and delivery inefficiency. Peptide self‑assembly technology has emerged as a powerful platform to address these challenges, enabling enzyme‑responsive morphological transformation, multivalent target binding, subcellular localization, multifunctional co‑assembly, and artificial enzyme mimicry for precise PCD induction. Despite significant progress, a systematic classification of how peptide assemblies trigger distinct PCD pathways is still lacking. This review categorizes peptide self‑assembly‑induced tumor cell death into five major themes, including ferroptosis, pyroptosis, necroptosis, cuproptosis, and combined death. By summarizing the design principles, key evidence, and anti‑tumor outcomes, this review highlights the unique advantages of peptide self‑assembly. It provides a theoretical foundation for developing peptide‑based precision cancer therapies and aims to guide future research toward clinical translation and personalized treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Digital Medical Engineering, School of Biological Science and Medical Engineering, Southeast University, Nanjing, China.
- Department of Oncology, Shengjing Hospital, China Medical University, Shenyang, Liaoning, China.
ORCID-Profile: Guowei Liang, Xianbao Sun, Gaolin Liang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Jiangsu Shuang Chuang Team
Zitieren
APA
Ning, S., Xing, X., Chang, Y. K., Mao, M., Xu, H. D., Ma, Y., Liang, G., Sun, X., & Liang, G. (2026). Peptide Self‐Assembly for Enhanced Cancer Therapy via Immunogenic Programmed Cell Death: Ferroptosis, Pyroptosis, Necroptosis, and Cuproptosis. Macromolecular Rapid Communications. https://doi.org/10.1002/marc.70400
Vancouver
Ning S, Xing X, Chang YK, Mao M, Xu HD, Ma Y, et al. Peptide Self‐Assembly for Enhanced Cancer Therapy via Immunogenic Programmed Cell Death: Ferroptosis, Pyroptosis, Necroptosis, and Cuproptosis. Macromolecular Rapid Communications. 2026. doi:10.1002/marc.70400
BibTeX
@article{Ning2026,
author = {Ning, Shasha and Xing, Xinruo and Chang, Yun-Kai and Mao, Mengmeng and Xu, Hai-Dong and Ma, Yu and Liang, Guowei and Sun, Xianbao and Liang, Gaolin},
title = {Peptide Self‐Assembly for Enhanced Cancer Therapy via Immunogenic Programmed Cell Death: Ferroptosis, Pyroptosis, Necroptosis, and Cuproptosis},
journal = {Macromolecular Rapid Communications},
year = {2026},
doi = {10.1002/marc.70400}
}
EUVIMED